What is a commonly used oral agent for initial management of Clostridioides difficile infection?

What is a commonly used oral agent for initial management of Clostridioides difficile infection?

• A. Vancomycin (oral).
• B. Metronidazole.
• C. Rifaximin.
• D. Clindamycin.

Answer: (A)

Treating Clostridioides difficile infection requires delivering antibiotic activity directly to the colon where the bacteria reside. An oral form of vancomycin stays in the gut and achieves high concentrations there, making it highly effective for initial CDI. This local action, paired with strong cure rates and lower relapse risk compared to older options, makes oral vancomycin a preferred first-line choice for initial episodes. Metronidazole used to be common, but evidence shows it’s less effective, especially for initial disease, and is now less favored. Rifaximin isn’t reliable as monotherapy for initial CDI, and clindamycin is actually a drug that predisposes to CDI rather than treating it. So vancomycin is the best option among these for initial management.

Treating Clostridioides difficile infection requires delivering antibiotic activity directly to the colon where the bacteria reside. An oral form of vancomycin stays in the gut and achieves high concentrations there, making it highly effective for initial CDI. This local action, paired with strong cure rates and lower relapse risk compared to older options, makes oral vancomycin a preferred first-line choice for initial episodes. Metronidazole used to be common, but evidence shows it’s less effective, especially for initial disease, and is now less favored. Rifaximin isn’t reliable as monotherapy for initial CDI, and clindamycin is actually a drug that predisposes to CDI rather than treating it. So vancomycin is the best option among these for initial management.